ASSYSTEM : Invest Securities remains Buy, adjusts its target
"The nuclear cycle is still extremely buoyant, but it is a long-term business, even though organic growth is already accelerating (+15.8% in the first half of 2023)", stresses the analyst in charge of the file.
Similarly, while there are no major targets in the nuclear sector, management is showing patience regarding the disposal of its stakes in Framatome and Expleo", continues Invest Securities, which is only adjusting its assumptions at the margin.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction